Former AXA Framlington Biotechnology fund manager Andy Smith has joined biopharma specialist Mann Bioinvest to launch an income-focused fund in the coming weeks.
The Magna BioPharma Income fund, slated to launch around the end of Q1 2013, will be managed by Smith, with key decisions overseen by an investment committee. Boutique equity house Charlemagne Capital...
Unclear on job moves
Reforms not enough
McGhee joins from banking trade body
Our video series continues
In June 2016, immediately before the Brexit referendum, a curious thing happened.